Ascension must sell 7 ASCs to complete $3.9B AmSurg deal: FTC
Ascension→AmSurg
Jun 2, 2026
Ascension has acquired AmSurg, a ambulatory surgery business in Missouri, for $3.9B. AmSurg operates ambulatory surgery centers that support outpatient procedures, and Ascension seeks to expand its ASC footprint through strategic acquisition. The Federal Trade Commission proposed a consent order tied to the AmSurg acquisition, requiring Ascension acquisitions to divest seven ASCs as part of the merger acquisition. The healthcare M&A deal is announced and valued at $3.9 billion, reflecting a strategic acquisition by a strategic buyer in MO acquisitions.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Ascension→AmSurg
Jun 2, 2026
WVU Medicine→Independence Health System
Jun 2, 2026
Servier→Edgewise Therapeutics neuromuscular business
Jun 2, 2026
Hims & Hers Health→Eucalyptus
Jun 2, 2026
Ascension→AmSurg
Jun 2, 2026